As stated earlier this special program is a trial program which means it is only open to some selected persons and there are specific outcomes being monitored. About 400 people have been chosen to take part in the trial program. These persons will be given access to procure recreational cannabis products from designated pharmacies. The cannabis products to be used in this program will be produced by Pure Production which is based in Switzerland.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…